تخطى إلى المحتوى / Skip to content
Clinical Reference Hub

Readmission to Hospital

Unplanned return to hospital within 30 days of discharge.

Medical disclaimer: This page is an educational clinical-decision-support reference for licensed healthcare professionals. It is not a substitute for professional medical advice, diagnosis, or treatment. If you are a patient with symptoms, consult a qualified physician. Always verify dosing and guidance against current clinical guidelines and the cited references.

🩺What is Readmission to Hospital?

The LACE Index was developed by Dr. Carl van Walraven and colleagues in 2010 and published in the Canadian Medical Association Journal (CMAJ). It was derived from a cohort of 4,812 medical and surgical patients discharged from 11 teaching and community hospitals in Ontario, Canada. The score uses four components: L — Length of stay (categorized into 6 levels from 1 to ≥14 days, with weighted points 1-7), A — Acuity of the admission (3 points if admitted through the ED or as an urgent case, 0 otherwise), C — Comorbidity as measured by the Charlson Comorbidity Index (converted to a 0-5 point scale), and E — Emergency department visits in the 6 months prior to admission (0-4 visits, weighted 0-4 points). The total score ranges from 0 to 19. The LACE Index has been externally validated in multiple healthcare systems and demonstrates reasonable discriminative ability for 30-day readmission (c-statistic 0.68-0.78). It is widely used in hospital quality improvement programs, transition of care initiatives, and as a case-mix adjustment tool for readmission benchmarking.

ICD-10 Classification Code:Z51.8

🏥Signs & Symptoms

The following clinical signs and symptoms are commonly assessed when evaluating Readmission to Hospital:

  • Admitted from ED or Urgent
  • Hemoglobin <12 g/dL at Discharge
  • Oncology Service Discharge
  • Sodium <135 mEq/L at Discharge
  • Procedure During Hospitalization
  • Urgent/Emergent Index Admission
  • Admission from Nursing Home
  • Length of Stay ≥5 Days

🔬Causes & Etiology

The LACE Index was developed by Dr. Carl van Walraven and colleagues in 2010 and published in the Canadian Medical Association Journal (CMAJ). It was derived from a cohort of 4,812 medical and surgical patients discharged from 11 teaching and community hospitals in Ontario, Canada. The score uses four components: L — Length of stay (categorized into 6 levels from 1 to ≥14 days, with weighted points 1-7), A — Acuity of the admission (3 points if admitted through the ED or as an urgent case, 0 otherwise), C — Comorbidity as measured by the Charlson Comorbidity Index (converted to a 0-5 point scale), and E — Emergency department visits in the 6 months prior to admission (0-4 visits, weighted 0-4 points). The total score ranges from 0 to 19. The LACE Index has been externally validated in multiple healthcare systems and demonstrates reasonable discriminative ability for 30-day readmission (c-statistic 0.68-0.78). It is widely used in hospital quality improvement programs, transition of care initiatives, and as a case-mix adjustment tool for readmission benchmarking.

The HOSPITAL score was developed by Dr. John Donzé and colleagues at Brigham and Women's Hospital / Harvard Medical School, published in BMJ in 2013. It was derived from a cohort of 9,210 medical patients discharged from a tertiary care academic medical center. The acronym HOSPITAL represents 8 predictors: Hemoglobin <12 g/dL at discharge, Oncology service discharge, Sodium <135 mEq/L at discharge, Procedure during hospitalization (any therapeutic or diagnostic procedure), Index admission type (urgent/emergent admission), number of Admissions in the past 12 months (0-4+ categorized as 0-5 points), length of stay ≥5 days, and admission from a Nursing home. Total score ranges from 0 to 12. The score has been externally validated in multiple international cohorts with c-statistics of 0.71-0.78. The main advantage of HOSPITAL over LACE is its focus on potentially avoidable readmissions rather than all-cause readmissions, and its incorporation of modifiable risk factors (e.g., anemia, hyponatremia) that can be addressed during hospitalization.

⚠️Risk Factors

The following factors are known to increase the risk of developing or worsening Readmission to Hospital:

  • Length of Stay (days)
  • Charlson Comorbidity Index Score
  • ED Visits (Prior 6 Months)
  • Hospital Admissions (Past 12 Months)

📊Clinical Assessment & Risk Scoring

Healthcare professionals use these validated clinical calculators, diagnostic scales, and risk scoring systems to assess the severity, prognosis, or therapeutic dosing requirements for Readmission to Hospital:

  • LACE Index — Readmission Risk

    The LACE Index predicts the risk of unplanned 30-day hospital readmission or death. It combines Length of stay, Acuity of admission, Comorbidity (Charlson), and Emergency department visits in the prior 6 months into a single validated risk score.

  • HOSPITAL Score — Avoidable Readmission

    The HOSPITAL score predicts the risk of 30-day potentially avoidable hospital readmissions using 8 clinical variables. It was designed to identify patients at high risk for readmissions that might be prevented better transitional care.

🧬Diagnostic Logic & Scoring Breakdown

LOS: 1 day=1, 2=2, 3=3, 4-6=4, 7-13=5, ≥14=7. Acuity: 3 if admitted from ED or urgent, else 0. Charlson: 0=0, 1=1, 2=2, 3=3, ≥4=5. ED visits (past 6 months): 0=0, 1=1, 2=2, 3=3, ≥4=4.

📢Clinical Significance & Implications

Hospital readmissions are a major quality metric and cost driver in healthcare systems worldwide. The LACE Index is one of the most widely validated readmission prediction tools and is used by hospitals for risk stratification, resource allocation for transitional care programs, and as a risk-adjustment variable in readmission benchmarking. The index has been embedded in electronic health records and discharge planning workflows across Canada, the United States, and Europe. Studies have shown that LACE-guided transitional care interventions can reduce 30-day readmission rates by 15-30% in high-risk populations.

🛡️Prevention & Management

Evidence-based prevention and management strategies for Readmission to Hospital include:

  • Early follow-up within 7-14 days. Medication reconciliation and patient education recommended.
  • Intensive discharge planning and transitional care. Follow-up within 7 days. Home health referral and telehealth monitoring.
  • Enhanced discharge planning with 7-14 day follow-up. Medication reconciliation prior to discharge.
  • Intensive transitional care management program. Early follow-up within 7 days. Home health referral and telehealth monitoring.
  • The original score includes any therapeutic or diagnostic procedure. Imaging procedures (CT, MRI, ultrasound with contrast, interventional radiology) count, but simple plain radiographs and non-contrast CT without intervention typically do not.

Complications & Prognosis

Without proper management, Readmission to Hospital may lead to the following complications:

The HOSPITAL score specifically targets avoidable readmissions — those that might be prevented with better transitional care, medication reconciliation, and outpatient follow-up. Unlike all-cause readmission tools, HOSPITAL focuses on modifying clinical factors during the hospitalization. Studies have shown that HOSPITAL-identified high-risk patients benefit from intensive transitional care interventions, with some centers reporting 20-30% relative reductions in 30-day avoidable readmissions after implementing HOSPITAL-guided discharge planning. The score is particularly useful in academic medical centers and large community hospitals with diverse medical patient populations.

💡 Clinical Assessment Scenario Example

A 65-year-old man with diabetes (CCI=2), admitted from the ED for cellulitis, LOS 8 days, with 2 ED visits in the prior 6 months. L=5 (LOS 7-13), A=3 (ED admission), C=2 (CCI=2), E=2 (2 visits). Total LACE = 5+3+2+2 = 12/19 (high risk). Recommended: intensive transitional care with 7-day follow-up.

⚠️Clinical Assessment Pitfalls

  • Mistake: Counting planned ED visits (e.g., scheduled IV therapy) in the ED visits component

    Correction: Only count unplanned ED visits in the 6 months prior to admission. Scheduled or planned visits should not be included.

  • Mistake: Using total hospital days including days in the ED observation unit

    Correction: LOS should only include days after admission to an inpatient bed. Observation unit or ED holding time should not be counted.

  • Mistake: Using admission hemoglobin instead of discharge hemoglobin

    Correction: The HOSPITAL score uses the lowest hemoglobin in the 24 hours before discharge, not the admission value.

  • Mistake: Under-counting prior admissions

    Correction: Include all unplanned hospital admissions in the 12 months prior to the index admission, including transfers from other facilities.

🚑When to Seek Medical Attention

This reference supports clinical assessment of Readmission to Hospital; it does not replace urgent evaluation. Seek prompt in-person medical care if symptoms are severe, rapidly worsening, or life-threatening, or if you are unsure about a diagnosis or treatment plan. Patients should always consult their physician before starting or changing any therapy.

Frequently Asked Questions

Q: Can the LACE Index be used for all types of patients?

LACE was derived from general medical and surgical inpatients. It has been validated in various populations including cardiac, respiratory, and post-surgical patients. However, its performance may vary in highly specialized populations (e.g., psychiatric, obstetric) where disease-specific readmission tools may be more appropriate.

Q: What is a high-risk LACE score cutoff?

The original study used scores ≥10 as high risk. Many hospitals have adopted LACE ≥10 as the threshold for referral to intensive transitional care programs. Some institutions use lower cutoffs (≥7) depending on resource availability and baseline readmission rates.

Q: How is HOSPITAL different from LACE?

HOSPITAL specifically predicts potentially avoidable readmissions and includes modifiable risk factors (anemia, hyponatremia) that can be addressed during hospitalization. LACE predicts all-cause readmission and death. Both are used for discharge risk stratification, sometimes in combination.

Q: Does the procedure variable include imaging?

The original score includes any therapeutic or diagnostic procedure. Imaging procedures (CT, MRI, ultrasound with contrast, interventional radiology) count, but simple plain radiographs and non-contrast CT without intervention typically do not.

📚Evidence-Based References

[1]
van Walraven C, Dhalla IA, Bell C, et al. Derivation and validation of an index to predict early death or unplanned readmission after discharge from hospital to the community. CMAJ. 2010;182(6):551-557.PubMed (20194559)
[2]
Grunier A, Dhalla IA, van Walraven C, et al. Validation of the LACE Index to predict early death or unplanned readmission after discharge. J Hosp Med. 2011;6(8):444-450.
[3]
Donzé J, Aujesky D, Williams D, et al. Potentially avoidable 30-day hospital readmissions in medical patients: derivation and validation of a prediction model. BMJ. 2013;347:f5552.PubMed (24048695)
[4]
Donzé J, Lipsitz S, Bates DW, et al. Validation of the HOSPITAL score for identifying patients at high risk for potentially avoidable readmissions. J Hosp Med. 2014;9(11):710-715.
Call Us
WhatsApp